Xcout Intel
MELIUS HEALTH CARE SOLUTIONS, INC.
Melius Pharma is a Swedish clinical-stage pharmaceutical company that develops new treatments for severe diseases with high unmet clinical needs. Its primary focus is the development of its lead candidate, ME-015, as a treatment for chronic cough in patients with idiopathic pulmonary fibrosis (IPF).
Subscribe to see MELIUS HEALTH CARE SOLUTIONS, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MELIUS HEALTH CARE SOLUTIONS, INC. at a glance
MELIUS HEALTH CARE SOLUTIONS, INC. is a pharmaceuticals company headquartered in United States. Its most recent funding round raised $408,333 in July 2017. Xcout tracks 5 named people at MELIUS HEALTH CARE SOLUTIONS, INC., including Peter Heinrich (Chairman of the Board).
MELIUS HEALTH CARE SOLUTIONS, INC. leadership
- Peter HeinrichChairman of the Board
- Christer FåhraeusBoard Member
- Christine LemkeBoard Member
- Karl TobiesonBoard Member
- Niels SkjørbaekBoard Member
MELIUS HEALTH CARE SOLUTIONS, INC. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $408,333 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Get MELIUS HEALTH CARE SOLUTIONS, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on MELIUS HEALTH CARE SOLUTIONS, INC. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access